|
28/202322/03/2023Paxlovid® 150 mg/100 mg film-coated Tablets22/03/2023
|
18/202309/03/2023Calcium and Vitamin D Effervescent Tablets09/03/2023
|
15/202303/03/2023Chloral Hydrate 143mg/5mL Oral Solution03/03/2023
|
04/202316/01/2023Improving the Efficient Uptake of Generics on the Government Formulary List16/01/2023
|
123/202222/12/2022Change in Gliptin (Dipeptidyl Peptidase 4 (DPP-4) Inhibitor)22/12/2022
|
124/202222/12/2022Co-amoxiclav 625mg Tablets22/12/2022
|
121/202219/12/2022Paxlovid® 150 mg/100 mg film-coated tablets19/12/2022
|
118/202212/12/2022Exceptional Medicinal Treatment Request Form12/12/2022
|
51/202206/07/2022New Indications for Direct Oral Anticoagulant Tablets 07/07/2022
|
44/202224/06/2022Non-Sedating Antihistamines Tablets and Oral Solution24/06/2022
|
26/202229/04/2022Omalizumab 150mg Injections for Severe Chronic Urticaria29/04/2022
|
25/202228/04/2022Pregabalin 75mg, 150mg and 300mg Capsules28/04/2022
|
15/202217/03/2022Caffeine Citrate Solution for Infusion17/03/2022
|
83/202130/12/2021Four-Factor Prothrombin Complex Concentrate (4F-PCC)30/12/2021
|
68/202126/11/2021Voriconazole 200mg Vials26/11/2021
|
52/202129/09/2021Schedule V Amendments29/09/2021
|
51/202123/09/2021Levothyroxine 25mcg Tablets23/09/2021
|
47/202003/09/2021Brands of Mesalazine Rectal Foam03/09/2021
|
39/202109/07/2021Premixed Potassium Chloride Infusion Bags09/07/2021
|
40/202108/07/2021Empagliflozin 10mg and 25mg Tablets08/07/2021
|
37/202105/07/2021Brands of Soluble Insulin, Biphasic Insulin and Isophane Insulin05/07/2021
|
38/202105/07/2021New Cystic Fibrosis Treatment05/07/2021
|
28/202106/05/2021Lapatinib 250mg Tablets06/05/2021
|
26/202128/04/2021Ipilimumab 5mg/mL Concentrate for Solution for Infusion28/04/2021
|
10/202108/02/2021Change in Brand of Lithium Carbonate 400mg Prolonged Release Tablets08/02/2021
|
07/202104/02/2021New Indication for Everolimus 5mg and 10mg Tablets04/02/2021
|
31E/202023/11/2020Extension of validity of Schedule V cards and related entitlement documents23/11/2020
|
81/202023/11/2020Benign Prostatic Enlargement Form Update23/11/2020
|
79/202017/11/2020Sildenafil 20mg Tablets17/11/2020
|
80/202017/11/2020Lenalidomide 5mg, 10mg and 15mg Capsules17/11/2020
|
76/202016/11/2020Bendamustine Hydrochloride 25mg and 100mg Vials16/11/2020
|
74/202030/10/2020 Nilotinib 200mg Capsules30/10/2020
|
72/202020/10/2020Cinacalcet 30mg Tablets, Everolimus 0.25mg and 0.75mg Tablets and Tiopronin 250mg Tablets20/10/2020
|
70/202007/10/2020Biosimilar Etanercept 50mg Pre-filled Pen07/10/2020
|
69/202005/10/2020Umeclidinium 55 micrograms/dose Dry Powder Inhaler 05/10/2020
|
67/202030/09/2020New Treatment for Benign Prostatic Enlargement 30/09/2020
|
62/202002/09/2020Adalimumab 40mg Solution for Injection02/09/2020
|
63/202002/09/2020Extension of Validity of DH 75 Documents02/09/2020
|
48/202010/06/2020 Alprostadil 500 micrograms/mL Concentrate for Solution for Infusion10/06/2020
|
47/202020/05/2020Fulvestrant 250mg Solution for Injection20/05/2020
|
46/202014/05/2020Change in brand of Insulin14/05/2020
|
44/202021/04/2020Change in brand of Human Normal Immunoglobulin Intravenous Injection21/04/2020
|
40/202016/04/2020Change in Brand and Dose of Theophylline Prolonged Release Tablets16/04/2020
|
41/202016/04/2020Posaconazole 40mg/mL Suspension and Voriconazole 200mg Tablets16/04/2020
|
31/202018/03/2020Extension of validity of Schedule V cards and related entitlement documents18/03/2020
|
22/202027/02/2020Fosfomycin 3g Granules for Oral Solution28/02/2020
|
08/202024/01/2020Caspofungin 50mg and 70mg Infusion24/01/2020
|
05/202021/01/2020Abiraterone 500mg Tablets21/01/2020
|
01/202008/01/2020Mexiletine 200mg Capsules 08/01/2020
|
115/201914/11/2019Insulin Glargine 100 units/mL for Type 2 Diabetes Mellitus14/11/2019
|
98/201924/09/2019Benign Prostatic Enlargement24/09/2019
|
94/201916/09/2019Schedule V Amendments16/09/2019
|
95/201916/09/2019Biosimilar Adalimumab 40mg Pre-filled Syringes16/09/2019
|
91/2019 09/09/2019Cetuximab 5mg/mL Solution for Infusion 09/09/2019
|
46/201920/05/2019Nivolumab 10mg/mL Concentrate for Solution for Infusion20/05/2019
|
43/201915/05/2019Change in Hormone Replacement Therapy Tablets15/05/2019
|
28/201903/04/2019Bevacizumab 25mg/mL Vials03/04/2019
|
22/201907/03/2019Amendment to Legal Notice 58/2018 regarding the Exceptional Medicinal Treatment Committee07/03/2019
|
106/201806/12/2018Deletion of Potassium Chloride 600mg SR tablets from the Formulary06/12/2018
|
107/201806/12/2018Human Varicella-Zoster Immunoglobulin Injection06/12/2018
|
81/201803/10/2018Ajmaline 50mg/10mL injection03/10/2018
|
82/201803/10/2018Adenosine 3mg/mL in 10mL vials03/10/2018
|
83/201803/10/2018Hydrocortisone Foam Enema03/10/2018
|
74/201812/09/2018Validity Period of Schedule V Cards12/09/2018
|
63/201806/08/2018Use of Budesonide Nebuliser Solution06/08/2018
|
54/201811/07/2018Deletion of Fluvastatin and Changes in Statin Entitlement11/07/2018
|
52/201809/07/2018Deletion of Fluvastatin and Changes in Statin Entitlement09/07/2018
|
29/201828/06/2018Revocation of DH Circular 29/2018 Chloral Hydrate 143mg/5mL Oral Solution28/06/2018
|
34/201826/04/2018Methylphenidate 18mg and 36mg Prolonged Release Tablets26/04/2018
|
29/201816/04/2018Chloral Hydrate 143mg/5mL Oral Solution16/04/2018
|
25/201827/03/2018Exceptional Medicinal Treatment Form27/03/2018
|
18/201812/03/2018Total Parenteral Nutrition (Neonatal – Start-up)12/03/2018
|
15/201806/03/2018Set up of the Exceptional Medicinal Treatment Committee07/03/2018
|
102/201712/12/2017Oseltamivir 75mg Capsules14/12/2017
|
97/201729/11/2017Artesunate 60mg Powder and Solvent for Injection29/11/2017
|
96/201721/11/2017Biosimilar Etanercept 50mg Pre-Filled Pen22/11/2017
|
86/201717/10/2017Trametinib 2mg Tablets17/10/2017
|
84/201712/10/2017Revision in the White Blood Cell Count Monitoring schedule for patients on Clozapine12/10/2017
|
81/201704/10/2017Everolimus 5mg and 10mg Tablets and Dabrafenib 75mg Capsules04/10/2017
|
73/201713/09/2017Bevacizumab 100mg/4mL Vials14/09/2017
|
51/201725/07/2017Azacitidine 100mg Vials 25/07/2017
|
49/201712/07/2017Enzalutamide 40mg Capsules12/07/2017
|
44/201721/06/2017Mitomycin C 40mg Vials21/06/2017
|
38/201730/05/2017Deferasirox Film-Coated Tablets30/05/2017
|
39/201730/05/2017Renewal of Exceptional Medicinal Treatment30/05/2017
|
40/201730/05/2017Calcium Carbonate Tablets30/05/2017
|
10/201701/02/2017Capecitabine 150mg and 500mg Tablets01/02/2017
|
458/201630/12/2016Switchover of Schedule II (Pink Card) Diabetic Patients to Schedule V Entitlement04/01/2017
|
455/201626/12/2016Repaglinide Tablets27/12/2016
|
442/201602/11/2016Blood Glucose Test Strips for Diabetes Mellitus Type 103/11/2016
|
|
428/201607/10/2016Switchover Implementation Plan from Remicade® to Biosimilar Infliximab (Inflectra®/Remsima®)07/10/2016
|
422/201607/09/2016Change in Dose of Non-Formulary Exceptional Medicinal Treatment Items07/09/2016
|
183/201606/05/2016New Atomoxetine Request Form09/05/2016
|
126/201614/04/2016Ledipasvir-Sofosbuvir 90mg/400mg Tablets and Ribavirin 200mg Tablets14/04/2016
|
135/201606/04/2016New Diabetes Treatment07/04/2016
|
118/201624/03/2016Metoprolol 50mg Tablets for Cardiac CT Scans28/03/2016
|
76/201624/02/2016Endorsement of Schedule V Card Application Forms, Protocol Regulated Medicines Request Forms and Diagnostic Investigations Request Forms by Resident Specialists Performing Evening Out Patients Sessions at Mater Dei Hospital 26/02/2016
|
660/201515/12/2015Sugammadex 100mg/mL Injections18/12/2015
|
601/201523/11/2015Change in Budesonide 100 micrograms/dose Dry Powder Inhaler23/11/2015
|
602/201523/11/2015Capecitabine 150mg and 500mg Tablets23/11/2015
|
603/201523/11/2015Conjugate Quadrivalent Meningococcal Vaccine23/11/2015
|
482/201508/10/2015Methylphenidate Hydrochloride 18mg and 36mg Prolonged Release Tablets08/10/2015
|
456/201528/09/2015Sulphur Hexafluoride 8 microlitres Injection29/09/2015
|
366/201517/08/2015Use of Domperidone19/08/2015
|
367/201517/08/2015Updated Government Formulary List (July 2015)19/08/2015
|
372/201517/08/2015Simeticone 40mg/mL Oral Suspension19/08/2015
|
373/201517/08/2015Tirofiban 250mcg/mL Concentrate for Solution for Infusion19/08/2015
|
374/201517/08/2015Human Chorionic Gonadotrophin19/08/2015
|
345/201528/07/2015Designated Delegates for Medicines Entitlement Application Forms (Circular superseeded by Circular DH76/2016)29/07/2015
|
305/201524/06/2015Change in Brand of Clonazepam 0.5mg and 2mg Tablets25/06/2015
|
255/201527/05/2015Calcipotriol Ointment in 100g Tubes27/05/2015
|
58/201512/02/2015Mesalazine 400mg Modified Release Tablets12/02/2015
|
49/201504/02/2015Change in Brand of Theophylline 250mg Prolonged Release Tablets04/02/2015
|
12/201507/01/2015Gluten Free Dietary Items Voucher Scheme for Coeliac Patients09/01/2015
|
443/201425/11/2014Deletion of Phenytoin Capsules25/11/2014
|
442/201424/11/2014Updated Government Formulary List (November 2014)24/11/2014
|
342/201410/09/2014HGT Strips for Patients Under 1810/09/2014
|
340/201405/09/2014Argatroban 100mg/mL Concentrate for Solution for Infusion05/09/2014
|
321/201413/08/2014Deletion of Trifluoperazine 1mg Tablets13/08/2014
|
305/201404/08/2014Esmolol 10 mg/mL in 10 mL vials04/08/2014
|
304/201401/08/2014Warfarin Tablets01/08/2014
|
276/201408/07/2014Teriflunomide Tablets08/07/2014
|
277/201408/07/2014Exceptional Medicinal Treatment requests for Antibiotic Treatment08/07/2014
|
278/201408/07/2014Mannitol 15% Intravenous Infusion08/07/2014
|
279/201408/07/2014Updated Government Formulary List (July 2014)08/07/2014
|
239/201410/06/2014Morphine sulphate 10mg/ml injections10/06/2014
|
|
191/201414/05/2014Atenolol 50mg Scored Tablets14/05/2014
|
190/201413/05/2014Liothyronine Sodium 25 micrograms Tablets13/05/2014
|
178/201408/05/2014Dimethyl Fumarate Capsules08/05/2014
|
179/201408/05/2014Danaparoid Sodium 750units/0.6mL Injections08/05/2014
|
180/201408/05/2014Deletion of Prednisone Acetate 30mg Suppositories08/05/2014
|
150/201424/04/2014Amendment of the Fifth Schedule of the Social Security Act24/04/2014
|
145/201417/04/2014Deletion of Ketoconazole 200mg Tablets from the Government Formulary List17/04/2014
|
146/201417/04/2014Risk Management Plan of Perfalgan® (paracetamol 10mg/mL solution for infusion)17/04/2014
|
120/201408/04/2014Carbonic Anhydrase Inhibitors08/04/2014
|
110/201427/03/2014Atomoxetine 10mg, 18mg, 25mg, 40mg, and 60mg Capsules27/03/2014
|
106/201425/03/2014Fingolimod 0.5mg Capsules25/03/2014
|
89/201413/03/2014Recommendations to limit the long-term use of calcitonin injections13/03/2014
|
88/201412/03/2014Calcium Carbonate12/03/2014
|
72/201426/02/2014Fentanyl 25mcg and 50mcg Transdermal Patches26/02/2014
|
73/201426/02/2014Changes to the use of Metoclopramide26/02/2014
|
54/201411/02/2014Updated Government Formulary List (February 2014)11/02/2014
|
55/201411/02/2014Natalizumab 20mg/mL Infusion11/02/2014
|
|
384/201323/12/2013Updated Government Formulary List (December 2013)23/12/2013
|
375/201312/12/2013Issuing of Government Staff Members Entitlement to Free Medicines12/12/2013
|
367/201304/12/2013Hepatitis B reactivation with Rituximab04/12/2013
|
353/201318/11/2013Deletion of Ritodrine 10mg Tablets from the Government Formulary List18/11/2013
|
354/201318/11/2013Ciprofloxacin Suspension18/11/2013
|
343/201306/11/2013Azithromycin06/11/2013
|
331/201328/10/2013Daptomycin 500mg Injections28/10/2013
|
327/201323/10/2013Pharmacy Technology Course23/10/2013
|
312/201314/10/2013Updated Government Formulary List (October 2013)14/10/2013
|
303/201307/10/2013Review of Medicines Entitlement and Issuing of Patients’ Prescriptions07/10/2013
|
295/201301/10/2013Deletion of Trimipramine 10mg, 25mg and 50mg Tablets01/10/2013
|
209/201306/08/2013Shortage of Coal Tar Shampoo06/08/2013
|
85/201314/05/2013Clonazepam Tablets14/05/2013
|
72/201305/04/2013Simvastatin Tablets05/04/2013
|
60/201311/03/2013Betamethasone Valerate 0.025% Ointment in 100g Tubes and Betamethasone and Salicylic Acid 0.05% + 3% Ointment in 100g Tubes11/03/2013
|
61/201311/03/2013Human Chorionic Gonadotrophin11/03/2013
|
38/201312/02/2013Medicines Entitlement Unit Processes12/02/2013
|
33/201328/01/2013Updated Government Formulary List (January 2013)28/01/2013
|
549/201218/12/2012Exemestane 25mg Tablets18/12/2012
|
455/201228/11/2012Dementia Treatment28/11/2012
|
431/201213/11/2012Methotrexate 2.5mg Tablets13/11/2012
|
388/201229/10/2012Carbonic Anhydrase Inhibitors Eye Drops29/10/2012
|
369/201215/10/2012Sulpiride 200mg/5ml Syrup (40mg/ml)15/10/2012
|
286/201206/09/2012Protocol Regulation of Mupirocin Skin Ointment on the Government Formulary List06/09/2012
|
217/201224/07/2012Deletion of Sodium Fusidate Skin Preparations (Cream and Ointment) from the Government Formulary List24/07/2012
|
|
142/201222/05/2012Montelukast 4mg and 5mg Chewable Tablets22/05/2012
|
144/201222/05/2012Morphine 100mg MR Tablets22/05/2012
|
145/201222/05/2012Maraviroc 300mg Tablets22/05/2012
|
01/201226/04/2012DPA Memo: Schedule V Reform and Diabetes Mellitus Management26/04/2012
|
111/201203/04/2012Potassium Citrate 1.5g/5ml Mixture03/04/2012
|
105/201229/03/2012HMG CoA Reductase Inhibitors (Statins)02/04/2012
|
106/201229/03/2012Updated Government Formulary List (March 2012)02/04/2012
|
104/201228/03/2012Diabetes Management and Schedule V Applications (No Longer Valid. Superseded by Memo DPA 01/12)31/03/2012
|
100/201226/03/2012Reform of the Schedule V of the Social Security Act26/03/2012
|
83/201229/02/2012Teriparatide 20mcg/80mcl Solution for Injection in a Pre-filled Pen29/02/2012
|
84/201229/02/2012Montelukast 10mg Film-Coated Tablets29/02/2012
|
285/201123/12/2011Zoledronic Acid 5mg Vials23/12/2011
|
280/201115/12/2011Omalizumab 150mg Injections15/12/2011
|
246/201107/11/2011Combined Abacavir/Lamivudine 600mg/300mg Preparation07/11/2011
|
247/201107/11/2011Risperidone Depot Injections 25mg07/11/2011
|
230/201117/10/2011Rivaroxaban 10mg Film Coated Tablets17/10/2011
|
209/201130/09/2011Ertapenem 1g Powder for Solution for Infusion30/09/2011
|
210/201130/09/2011Patient Responsibility Regarding the Correct Storage of Medicines30/09/2011
|
195/201131/08/2011Rocuronium Bromide Injections31/08/2011
|
174/201109/08/2011Deletion of Ticlopidine & Changeover to Clopidogrel09/08/2011
|
166/201125/07/2011Long-acting Beta2 Agonist Inhalation Powder in Capsules (Foradil®)25/07/2011
|
150/201128/06/2011Trabectedin 0.25mg and 1mg Vials28/06/2011
|
151/201128/06/2011Beta Blocker - Preservative Free Eye Drops28/06/2011
|
152/201128/06/2011Linezolid 600mg Tablets and 600mg Vials28/06/2011
|
146/201122/06/2011Updated Government Formulary List (June 2011)22/06/2011
|
144/201117/06/2011Long-acting Beta2 Agonist Inhalation Powder17/06/2011
|
111/201118/05/2011HMG CoA Reductase Inhibitors (Statins) Protocol and Request Form18/05/2011
|
107/201110/05/2011New Antacid Compound Preparation10/05/2011
|
108/201110/05/2011Pregabalin 75mg, 150mg and 300mg Capsules10/05/2011
|
91/201111/04/2011Medicines Entitlement Unit Application Forms11/04/2011
|
79/201130/03/2011Rasburicase 1.5mg and 7.5mg Injections30/03/2011
|
71/201121/03/2011Replacement of DH CIRCULAR No. 51/2011 for Clopidogrel Tablets, 75mg22/03/2011
|
50/201123/02/2011Deferasirox 250mg and 500mg Dispersible Tablets23/02/2011
|
51/201123/02/2011Clopidogrel Tablets 75 mg23/02/2011
|
48/201122/02/2011Pemetrexed 100mg and 500mg Vials22/02/2011
|
41/201109/02/2011Lanthanum Carbonate 750mg Chewable Tablets09/02/2011
|
259/201011/11/2010PPIs: Esomeprazole I.V. Powder for Reconstitution, 40mg Vial and Omeprazole I.V. Injection Powder for Reconstitution 40mg Vial16/11/2010
|
260/201011/11/2010Enoxaparin Sodium Solution for Injection16/11/2010
|
248/201003/11/2010Aprepitant Capsules03/11/2010
|
249/201003/11/2010New Medicine on the Government Formulary List: Rasigiline 1mg Tablets03/11/2010
|
224/201011/10/2010Extended Customer Care Telephone Service at Medicines Approval Section within the Medicines Entitlement Unit, DPPM11/10/2010
|
223/201007/10/2010Schedule V Applications and Cards11/10/2010
|
191/201017/08/2010Change-over from Insulin Aspart Vials to Cartridges18/08/2010
|
175/201027/07/2010Entitlement for Patients with Spinal Cord Pathologies27/07/2010
|
154/201009/07/2010Sodium Bicarbonate 8.4% 10mL Ampoules for Use with Diclofenac Injections for IV Infusions09/07/2010
|
151/201028/06/2010Updated Government Formulary List (June 2010) and Launch of Website DPPM05/07/2010
|
122/201024/05/2010Integration and Migration of Medicines Approval Section (MAS) and Schedule V Offices26/05/2010
|
118/201008/05/2010Switchover from Neo-Recormon® to Eprex®20/05/2010
|
61/201008/03/2010Lactulose Syrup09/03/2010
|
34/201015/02/2010Co-Amoxiclav and Amoxicillin Combination16/02/2010
|
21/201002/02/2010Klean Prep® and Picolax® as Bowel Cleansing Agents for Hospital Use03/02/2010
|
05/201007/01/2010Change-over from Insulin Glargine (Lantus®) Vials to Cartridges13/01/2010
|
271/200909/11/2009Switching Over from Venlafaxine 37.5mg to Venlafaxine XL 75mg Prolonged-Release Capsules11/11/2009
|
259/200926/10/2009Switching Over of Epilim® EC Tablets to Epilim® Chrono Tablets29/10/2009
|
252/200912/10/2009Zoledronic Acid Preparations19/10/2009
|
256/200912/10/2009Correction of DH Circular No.252/2009 (annexes attached to DH Circular No. 252/2009 are still valid)12/10/2009
|
242/200906/10/2009Calcium Effervescent Tablets07/10/2009
|
237/200925/09/2009Updated Government Formulary List (September 2009)28/09/2009
|
204/200913/08/2009Prescription of Aspirin 75mg Tablets19/08/2009
|
187/200924/07/2009Finasteride Tablets 5mg and Potassium Citrate Effervescent Tablets 1.5mg24/07/2009
|
105/200902/06/2009Calcium Supplementation with Zoledronic Acid in Paget’s Disease02/06/2009
|
128/200922/04/2009New Opening Hours of the Schedule V Office12/05/2009
|
77/200906/03/2009Domperidone 10mg Suppositories16/03/2009
|
35/200927/02/2009Sodium Cromoglycate Inhaler04/03/2009
|
64/200927/02/2009Schedule V Card for Malignant Diseases04/03/2009
|
38/200923/02/2009Changeover in Fenofibrate Preparation04/03/2009
|
46/200913/02/2009Schedule V card for HIV patients23/02/2009
|
102/200801/10/2008Directorate for Pharmaceutical Policy and Monitoring (DPPM)09/10/2008
|
103/200801/10/2008Calcium Carbonate Tablets09/10/2008
|
88/200828/08/2008Introduction of Prescribing Protocol for Glycopeptides and New Request Form for Reserve Antibiotics03/09/2008
|
84/200818/08/2008Human Anti-D Immunoglobulin19/08/2008
|
75/200801/08/2008Enoxaparin (Clexane®)14/08/2008
|
54/200827/06/2008Long Acting Beta2-Agonists27/06/2008
|
3/200826/03/2008Change-Over of Long Acting Beta2-Agonists27/03/2008
|
167/200729/10/2007Candesartan and Valsartan Interchange06/11/2007
|
119/200724/07/2007Temporary replacement of Heparin Calcium24/07/2007
|
95/200726/06/2007Filgrastim Temporary Change in Formulation26/06/2007
|
63/200724/05/2007Replacement of Fenofibrate 300mg Capsules with Fenofibrate 200mg24/05/2007
|
67/200724/05/2007Change-over of Carbonic Anhydrase Inhibitor Eye Drops24/05/2007
|
64/200720/03/2007Properties of the Lidocaine 1% Injection Currently and Temporarily Available20/03/2007
|
50/200706/03/2007Properties of the Anti-D Immunoglobulin Preparation Currently Available09/03/2007
|
07/200704/01/2007Replacement of the Tetanus Vaccine with the Combined Diphtheria/Tetanus05/01/2007
|
03/200703/01/2007Change in Humulin Insulin Cartridges Trade Names04/01/2007
|
354/200615/12/2006Procedure for Authorisation of Schedule V Treatment by the Department of Psychiatry18/12/2006
|
311/200609/11/2006Entitlement to Statins 13/11/2006
|
00/200717/10/2006Konakion MM Paediatric24/05/2007
|
250/200610/08/2006Statins Interchange Clarification11/08/2006
|
234/200619/07/2006Fluvastatin 80mg and Simvastatin 20mg Interchange Update21/07/2006
|
214/200622/06/2006Fluvastatin 80mg and Simvastatin 20mg Interchange26/06/2006
|
87/200601/03/2006Non-Formulary Psychiatric Drugs02/03/2006
|
258/200517/11/2005Fluorouracil 250mg Capsules Deletion18/11/2005
|
252/200511/11/2005Bendrofluazide 2.5mg for the Treatment of Hypertension16/11/2005
|
203/200528/09/2005Monotard® and Ultratard® deletion29/09/2005
|
105/200510/06/2005Entitlement of Patients Suffering from Osteoporosis to Free Treatment13/06/2005
|
106/200510/06/2005Deletion of Flurazepam 15mg and 30mg Capsules from the Formulary of GHS13/06/2005
|
83/200511/05/2005Review of Respiratory Drugs Protocols12/05/2005
|
84/200511/05/2005Review of Chapter of Ulcer Healing Drugs12/05/2005
|
|